Achieve Life Sciences, Inc. (ACHV) — Stock Score Summary

Achieve Life Sciences, Inc. (ACHV) has a MoatMap StockRank of 19/100 based on Quality (18/100), Value (33/100), and Momentum (54/100) factor scores. The current signal is STRONG SELL. Achieve Life Sciences, Inc. is a small-cap healthcare company whose operations are not directly impacted by or benefiting from the identified macro themes. It lacks the characteristics of a quality compounder with an unpriced macro tailwind.

Achieve Life Sciences, Inc. is a specialty pharmaceutical company focused on developing and commercializing cytisinicline for the treatment of nicotine addiction. Positioned to address a significant unmet medical need, its proprietary formulation of cytisinicline is in late-stage clinical development. The company is single-asset focused, directing resources towards regulatory approval and subsequent commercialization of its lead candidate.

Key Financial Metrics

Price$4.69
Market Cap$481M
P/E (Forward)-9.60
Price/Book22.25
Return on Equity-496.1%
Return on Invested Capital-164.6%
Debt/Equity140.03
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-27M

Achieve Life Sciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Achieve Life Sciences, Inc.’s (ACHV) StockRank?
MoatMap’s StockRank for Achieve Life Sciences, Inc. (ACHV) is 19/100, with a Strong Sell signal. It is a composite of Quality (18), Value (33), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Achieve Life Sciences, Inc. have an economic moat?
Achieve Life Sciences, Inc. (ACHV) has a Quality factor score of 18/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Achieve Life Sciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Achieve Life Sciences, Inc. (ACHV) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Achieve Life Sciences, Inc. in?
Achieve Life Sciences, Inc. (ACHV) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksACHV deep dive reportAI ChampionsHow we score stocksSense-check another stock